News from GUERBET A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 17, 2017, 11:26 ET Agentes de contraste con gadolinio: actualización de las recomendaciones del PRAC

Guerbet (FR0000032526 GBT), un especialista mundial en productos y soluciones de contraste para imágenes médicas, toma conocimiento...


Mar 16, 2017, 15:25 ET Mezzi di contrasto a base di gadolinio: aggiornamento sulle raccomandazioni del PRAC

Guerbet (FR0000032526 GBT), specialista globale nel campo dei mezzi di contrasto e delle soluzioni per l'imaging, ha preso atto oggi delle...


Mar 16, 2017, 08:46 ET Kontrastmittel auf Gadolinium-Basis: Neueste Informationen zu PRAC-Empfehlungen

Guerbet (FR0000032526 GBT), ein globaler Spezialist für Kontrastmittel und -lösungen zur medizinischen Bildgebung gab heute die vom Ausschuss für...


Mar 14, 2017, 06:10 ET Guerbet: Agents de contraste à base de gadolinium : mise à jour des recommandations du PRAC

In the news release, "Agents de contraste à base de gadolinium : mise à jour des recommandations du PRAC" issued on 13 Mar 2017 19:44...


Feb 01, 2017, 10:04 ET Guerbet Expands Distribution Partnership in Canada with Methapharm

Longstanding Distribution Partner Will Now Offer Full Guerbet Product Line in Canada Guerbet (FR0000032526 GBT), the global specialist in...


Nov 15, 2016, 02:00 ET Guerbet, un nuevo líder global en ruta hacia el futuro

En 90 años, el grupo ha creado una historia de éxito en innovación y se compromete con el crecimiento de sus ambiciones internacionales...


Nov 15, 2016, 02:00 ET Guerbet, un nouveau leader mondial de l'imagerie en route vers le futur

En 90 ans, le groupe a construit sa success story sur l'innovation et porte désormais plus haut ses ambitions à l'international Guerbet...


Nov 15, 2016, 02:00 ET Guerbet, nuovo leader globale che guarda al futuro

In 90 anni il Gruppo ha costruito il suo successo sull'innovazione ed è impegnato a rafforzare la propria presenza sul mercato internazionale...


Nov 15, 2016, 02:00 ET Guerbet - ein neuer globaler Marktführer auf dem Weg in die Zukunft

Innerhalb von 90 Jahren konnte der Konzern seine Erfolgsgeschichte auf Innovation aufbauen und hat sich nun vorgenommen, einen internationalen...


Jun 23, 2016, 07:00 ET Guerbet Honored With Supplier Horizon Award from Premier Inc.

 Guerbet announced today that it has been named a winner of Premier Inc.'s Supplier Horizon Award. One of 12 suppliers to receive the award...


Feb 11, 2016, 08:30 ET Guerbet receives FDA 510k clearance for the OptiOne™ Single-Head Contrast Delivery System

 Guerbet announced that it has received 510K clearance from the US Food and Drug Agency (FDA) for its OptiOne™ Single-Head Contrast...


Jul 25, 2013, 12:45 ET First Injection of Dotarem® (gadoterate meglumine) in US Performed at Cincinnati Children's Hospital Medical Center

 Guerbet announced today that Cincinnati Children's Hospital Medical Center (Cincinnati Children's) last week performed the first US injection...


Apr 11, 2013, 08:23 ET La FDA aprobó el Dotarem® (gadoterato de meglumina), primer medio de contraste macrocíclico e iónico basado en gadolinio de los Estados Unidos

Guerbet anunció hoy que la Administración de Fármacos y Alimentos estadounidense (Food and Drug Administration, FDA) aprobó el...


Apr 11, 2013, 07:30 ET FDA aprova Dotarem® (ácido gadotérico), primeiro agente de contraste macrocíclico e iônico à base de gadolínio dos EUA

 Guerbet anunciou hoje que o FDA (US Food and Drug Administration) aprovou  Dotarem® (ácido gadotérico), um agente de...


Apr 02, 2013, 02:24 ET La FDA aprueba Dotarem® (ácido gadotérico)

- La FDA aprueba Dotarem® (ácido gadotérico), el primer agente de contraste iónico macrocíclico basado en...


Mar 29, 2013, 05:13 ET FDA erteilt Zulassung für Dotarem® (Gadotersäure), das erste makrozyklische und ionische gadoliniumhaltige Kontrastmittel in den USA

Guerbet gab heute bekannt, dass die US Food und Drug Administration (FDA) die Zulassung für Dotarem® (Gadotersäure), ein...


Mar 28, 2013, 09:46 ET La FDA approva Dotarem® (gadoterate meglumine), il primo agente di contrasto macrociclico ionico a base di gadolinio negli USA

Guerbet ha annunciato oggi che la US Food and Drug Administration (FDA) ha approvato Dotarem® (gadoterate meglumine), mezzo di contrasto a...


Mar 27, 2013, 13:00 ET La FDA autorise Dotarem® (gadotérate de méglumine), premier produit de contraste macrocyclique et ionique à base de gadolinium aux Etats-Unis

Guerbet, spécialiste des produits de contraste pour l'imagerie médicale, annonce que la Food and Drug Administration (FDA)...


Feb 14, 2013, 17:07 ET Medical Imaging Drugs Advisory Committee Recommends Approval of Guerbet NDA for Dotarem® (gadoterate meglumine)

Guerbet, the contrast agent specialist for medical imaging, today announced that the Medical Imaging Drugs Advisory Committee to US Food and Drug...


Oct 27, 2006, 01:00 ET Guerbet - Another Proof That There is no Difference Between Low-Osmolarity Contrast Agents and Iso-Osmolar Agent for Prevention of Contrast-Induced Nephropathy

WASHINGTON, October 27 /PRNewswire/ -- Results from a recent clinical trial demonstrated that contrast agents Hexabrix(R) (Ioxaglate) and...